Cargando…

Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design

Various bacterial species cycle between growth phases and biofilm formation, of which the latter facilitates persistence in inhospitable environments. These phases can be generally characterized by one or more cellular phenotype(s), each with distinct virulence factor functionality. In addition, a v...

Descripción completa

Detalles Bibliográficos
Autores principales: Beitelshees, Marie, Hill, Andrew, Jones, Charles H., Pfeifer, Blaine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073711/
https://www.ncbi.nlm.nih.gov/pubmed/29949876
http://dx.doi.org/10.3390/ma11071086
_version_ 1783344250174308352
author Beitelshees, Marie
Hill, Andrew
Jones, Charles H.
Pfeifer, Blaine A.
author_facet Beitelshees, Marie
Hill, Andrew
Jones, Charles H.
Pfeifer, Blaine A.
author_sort Beitelshees, Marie
collection PubMed
description Various bacterial species cycle between growth phases and biofilm formation, of which the latter facilitates persistence in inhospitable environments. These phases can be generally characterized by one or more cellular phenotype(s), each with distinct virulence factor functionality. In addition, a variety of phenotypes can often be observed within the phases themselves, which can be dependent on host conditions or the presence of nutrient and oxygen gradients within the biofilm itself (i.e., microenvironments). Currently, most anti-biofilm strategies have targeted a single phenotype; this approach has driven effective, yet incomplete, protection due to the lack of consideration of gene expression dynamics throughout the bacteria’s pathogenesis. As such, this article provides an overview of the distinct phenotypes found within each biofilm development phase and demonstrates the unique anti-biofilm solutions each phase offers. However, we conclude that a combinatorial approach must be taken to provide complete protection against biofilm forming bacterial and their resulting diseases.
format Online
Article
Text
id pubmed-6073711
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60737112018-08-13 Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design Beitelshees, Marie Hill, Andrew Jones, Charles H. Pfeifer, Blaine A. Materials (Basel) Review Various bacterial species cycle between growth phases and biofilm formation, of which the latter facilitates persistence in inhospitable environments. These phases can be generally characterized by one or more cellular phenotype(s), each with distinct virulence factor functionality. In addition, a variety of phenotypes can often be observed within the phases themselves, which can be dependent on host conditions or the presence of nutrient and oxygen gradients within the biofilm itself (i.e., microenvironments). Currently, most anti-biofilm strategies have targeted a single phenotype; this approach has driven effective, yet incomplete, protection due to the lack of consideration of gene expression dynamics throughout the bacteria’s pathogenesis. As such, this article provides an overview of the distinct phenotypes found within each biofilm development phase and demonstrates the unique anti-biofilm solutions each phase offers. However, we conclude that a combinatorial approach must be taken to provide complete protection against biofilm forming bacterial and their resulting diseases. MDPI 2018-06-26 /pmc/articles/PMC6073711/ /pubmed/29949876 http://dx.doi.org/10.3390/ma11071086 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Beitelshees, Marie
Hill, Andrew
Jones, Charles H.
Pfeifer, Blaine A.
Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design
title Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design
title_full Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design
title_fullStr Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design
title_full_unstemmed Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design
title_short Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design
title_sort phenotypic variation during biofilm formation: implications for anti-biofilm therapeutic design
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073711/
https://www.ncbi.nlm.nih.gov/pubmed/29949876
http://dx.doi.org/10.3390/ma11071086
work_keys_str_mv AT beitelsheesmarie phenotypicvariationduringbiofilmformationimplicationsforantibiofilmtherapeuticdesign
AT hillandrew phenotypicvariationduringbiofilmformationimplicationsforantibiofilmtherapeuticdesign
AT jonescharlesh phenotypicvariationduringbiofilmformationimplicationsforantibiofilmtherapeuticdesign
AT pfeiferblainea phenotypicvariationduringbiofilmformationimplicationsforantibiofilmtherapeuticdesign